Geron (GERN) Amortizatization of Intangibles (2010 - 2026)
Geron's (GERN) quarterly Amortizatization of Intangibles came in at $192000.0 in Q1 2026, up 8.47% year-on-year from $177000.0 in Q1 2025, and up 2.13% quarter-over-quarter from $188000.0 in Q4 2025.
Geron (GERN) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Geron has disclosed Amortizatization of Intangibles across 17 years of filings, most recently posting $192000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $192000.0, up 8.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $745000.0 (down 92.32% YoY), and the FY2025 annual result was $730000.0, down 92.46% from the prior year.
- Amortizatization of Intangibles came in at $192000.0 for Q1 2026 at Geron, up from $188000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $8.0 million in Q3 2023 to a low of -$445000.0 in Q2 2022.
- The 5-year median for Amortizatization of Intangibles is $181000.0 (2025), against an average of $1.3 million.
- Across the five-year window, Amortizatization of Intangibles soared 1789.26% in 2023 and sank 97.35% in 2025, its largest moves.
- Geron's Amortizatization of Intangibles stood at $149000.0 in 2022, then jumped by 1789.26% to $2.8 million in 2023, then slipped by 14.67% to $2.4 million in 2024, then plunged by 92.17% to $188000.0 in 2025, then gained by 2.13% to $192000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $192000.0 (Q1 2026), $188000.0 (Q4 2025), and $184000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 192,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 192,000.00 |
| Mar 31, 2026 | 192,000.00 |
| Dec 31, 2025 | 188,000.00 |
| Dec 31, 2025 | 188,000.00 |
| Sep 30, 2025 | 184,000.00 |
| Sep 30, 2025 | 184,000.00 |
| Jun 30, 2025 | 181,000.00 |
| Jun 30, 2025 | 181,000.00 |
| Mar 31, 2025 | 177,000.00 |
| Mar 31, 2025 | 177,000.00 |
| Dec 31, 2024 | 2.40 Mn |
| Dec 31, 2024 | 2.40 Mn |
| Sep 30, 2024 | 6.95 Mn |
| Sep 30, 2024 | 6.95 Mn |
| Jun 30, 2024 | 167,000.00 |
| Jun 30, 2024 | 167,000.00 |
| Mar 31, 2024 | 164,000.00 |
| Mar 31, 2024 | 164,000.00 |
| Dec 31, 2023 | 2.82 Mn |
| Dec 31, 2023 | 2.82 Mn |